JACKSONVILLE, Fla. — In 2019, after a routine vaccination, 11-year-old Keithron Thomas felt a sharp pain in his shoulder and down his arm. His mother, Melanie Bostic, thought it would go away after a few days. But days turned to weeks, then months, and years. Bostic learned of a federal program designed to help people…
“The future is here,” the email announced. Hilda Jaffe, then 88, was letting her children know she planned to sell the family home in Verona, New Jersey. She’d decided to begin life anew — on her own — in a one-bedroom apartment in Hell’s Kitchen in Manhattan. Fourteen years later, Jaffe, now 102, still lives…
Health-tech pilots don’t usually fail because the product is bad. They fail because the system was never wired to absorb it. The post Stop Pitching the Institute — Pitch the Stack appeared first on MedCity News.
Over 253,000 instances of care were provided by Duke to State Health Plan members in 2025
Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it’s encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers. The post Drug-Gene Testing: Key to Safer Cancer Treatment appeared first on MedCity News.
Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Trump Team’s Rhetoric Doesn’t Match Actions The recent KFF Health News article “Beyond Ivy League, RFK Jr.’s NIH Slashed Science Funding Across States That Backed Trump” (April 17) struck a nerve….
Don’t delay — enroll today! Open Enrollment for 2025 health insurance is here. Enroll in a new plan or change your coverage for the year ahead. Enroll by December 15, so your coverage can start January 1. Open Enrollment ends on January 15, 2025. Image Apply and enroll at HealthCare.gov There are several ways to…
This tracker provides an overview of state laws/policies restricting minor access to gender affirming care and any associated litigation by state, identifying which groups of people are impacted in addition to minors, the types of penalties providers face, the status of legal challenges, and other key information.
By KIM BELLARD Vaccine experts are going rogue in response to RFK Jr’s attacks on vaccine safety. Health insurers promise – honest…this time – to make prior authorizations less burdensome (although not, of course, to eliminate them). ChatGPT and other LLMs may be making us worse at learning. So many things to write about, but…
Vesalius Therapeutics’ AI-based technology finds novel targets and intervention points for subgroups of patients within a common disease. A small molecule that Vesalius has been developing for a novel Parkinson’s disease target is now headed to GSK, which has licensed global rights. The post GSK Wagers $80M on a Tech Platform and Parkinson’s Drug from…